Study on the Prevention of Recidivism and the Consequences of Sexual Violence Suffered by Female Asylum Seekers in France

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18+
SponsorAssistance Publique Hopitaux De Marseille

About this trial

Women seeking asylum (WSA) are overexposed to sexual violence (SV) in their countries of origin, along migration routes, and within host countries. This overexposure does not cease upon arrival in host countries; on the contrary, the first months following arrival are characterised by heightened vulnerability, with an increased incidence of sexual violence, particularly among women with a prior history of victimisation.

Sexual violence has major consequences on physical health, mental health, quality of life, and healthcare utilisation, and generates substantial individual and societal costs. International organisations, including the United Nations High Commissioner for Refugees, have identified the prevention of sexual violence and the improvement of care for survivors as public health priorities.

Previous work suggests that addressing sexual violence within primary care, when embedded in a comprehensive, culturally informed, and coordinated approach integrating medical, psychological, social, and medico-legal dimensions, may contribute to preventing the occurrence or recurrence of sexual violence in host countries. However, no comparative study has yet evaluated the effectiveness of such a coordinated model of care on the prevention of sexual violence among women seeking asylum, nor assessed its efficiency or transferability.

The primary objective of this study is to evaluate the effectiveness of a coordinated, transcultural, multidisciplinary outpatient care model on the prevention of sexual violence occurring in host European countries among women seeking asylum.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Woman seeking asylum in France

Asylum application registered less than 3 months before inclusion.

Self-identified female gender.

Age ≥ 18 years.

Disqualifiers

Re-examination of a previous asylum application.

Major cognitive impairment (e.g. dementia or intellectual disability) preventing reliable collection of study outcomes.

Trial population

Female seeking asylum in France

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • care coordinator

    Other intervention

    The care coordinator ensures organisation of the care pathway, liaison between professionals, and longitudinal follow-up in collaboration with a general practitioner.

  • a trained health mediator

    Other intervention

    The health mediator facilitates communication, supports participants in navigating healthcare and social systems, and helps reduce linguistic, cultural, and administrative barriers.

  • Access to care in the usual care

    Other intervention

    Depends on asylum seekers' individual initiatives

  • Access to care in the Coordinated care model

    Other intervention

    Systematically initiated from registration at the first reception centre (PADA)

  • Coordination

    Other intervention

    Fragmented, dependent on local structures

  • Coordination

    Other intervention

    Provided by a coordinating care professionnal

  • Detection of sexual violence

    Other intervention

    Based on victims' self-reporting

  • Detection of sexual violence

    Other intervention

    Proactive approach with health mediation and training of healthcare professionals

  • Medical follow-up

    Other intervention

    Irregular, often interrupted due to precarious living conditions

  • Medical follow-up

    Other intervention

    Progressive integration into mainstream healthcare services

  • Training of professionals

    Other intervention

    Variable, not standardized

  • Training of professionals

    Other intervention

    Specialized and systematic training on sexual violence

Treatment groups

675 Participants
are divided into 2 treatment groups
Group A: Coordinated care model7 interventions
Group B: Comparator - Usual care5 interventions

Trial outcomes

Primary outcomes

1

Occurrence of sexual violence within 12 months after inclusion

The primary outcome is the occurrence of sexual violence during the first 12 months following inclusion. Sexual violence is defined as the occurrence of at least one of the following events: rape, attempted rape, sexual assault, or sexual exhibition, as assessed through structured interviews administered at follow-up visits.

Time frame
12 months after inclusion

Secondary outcomes

1

Occurrence of rape within 12 months after inclusion

Occurrence of rape during the first 12 months following inclusion, assessed through structured interviews

Time frame
12 months after inclusion
2

Occurrence of sexual violence between 12 and 18 months after inclusion

Occurrence of sexual violence events (rape, attempted rape, sexual assault, or sexual exhibition) during the period between 12 and 18 months following inclusion.

Time frame
12 to 18 months after inclusion
3

Occurrence of rape between 12 and 18 months after inclusion

Occurrence of rape events reported between 12 and 18 months following inclusion.

Time frame
12 to 18 months after inclusion
4

Measurement and Assessment of somatic symptoms

Somatic health assessed using the Cumulative Illness Rating Scale (CIRS).This scale, consisting of 14 items each corresponding to an organ system. Score ranged from 0 to 4, with lower scores indicating better health.

Time frame
at Baseline

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.